Lisata Therapeutics (LSTA) Earnings Date & Reports
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
LSTA is expected to report earnings to rise 34.55% to -74 cents per share on May 07
Q1'25
Est.
$-0.74
Q4'24
Beat
by $0.30
Q3'24
Beat
by $0.16
Q2'24
Beat
by $0.14
Q1'24
Beat
by $0.14
The last earnings report on February 27 showed earnings per share of -55 cents, beating the estimate of -84 cents. With 15.93K shares outstanding, the current market capitalization sits at 17.84M.